Wakunaga of America has announced that a specific compound found in Kyolic Aged Garlic Extract — known as S-1-propenyl-L-cysteine or S1PC — demonstrated in a peer-reviewed study the ability to counteract skeletal muscle aging by activating an inter-organ communication pathway that connects fat tissue to the brain, which then enhances signalling to muscles.
Published in Cell Metabolism, the research showed that long-term S1PC treatments in aged mice produced significantly increased skeletal muscle force, restored body temperatures to youthful levels, and reduced overall frailty index scores. A randomized double-blind clinical trial in healthy middle-aged humans found that a single oral dose of S1PC-enriched garlic powder successfully increased circulating levels of the key enzyme eNAMPT in subjects with healthy body fat mass.
Wakunaga of America is a company with a decades-long history of researching medicinal herbs.
Image Credit: Wakunaga of America
What's Driving This Trend
- Garlic-derived Bioactives
- Discovery of S1PC highlights small-molecule organosulfur compounds as a new class of bioactives that could redefine natural-product pipelines for muscle-support therapeutics.
- Inter-organ Signaling Therapeutics
- Research linking adipose-to-brain-to-muscle communication reveals signaling pathways as therapeutic targets that could enable drugs or biologics to systemically reverse age-related muscle decline.
- Nutraceuticals for Sarcopenia
- Clinical evidence of an oral garlic-derived ingredient increasing eNAMPT levels suggests evidence-backed nutraceuticals may compete with conventional interventions for preserving muscle function in aging populations.
Who This Affects Most
- Pharmaceuticals
- Translating S1PC mechanisms into synthetic analogs or repurposed drugs presents opportunities for new prescription treatments addressing frailty and sarcopenia.
- Nutraceuticals and Supplements
- Companies producing standardized, clinically validated garlic formulations could disrupt supplement markets by offering measurable biomarker-responsive products for middle-aged and elderly consumers.
- Functional Food Manufacturing
- Incorporation of S1PC-enriched ingredients into fortified foods offers possibilities for mainstream dietary products that deliver clinically relevant muscle-support benefits.
